The Era of Provisional Stenting for Bifurcations Comes to an End

After the large studies which set provisional stenting as the preferred strategy to treat bifurcations comes the double kissing crush technique (DK crush) to break the mold once again. This time, the DK crush technique is tested against provisional stenting in the left main, with a 3-year follow-up.

Técnica Doble Crush Doble Kissing vs. stent provisional

The DKCRUSH-V, soon to be published in J Am Coll Cardiol Intv, randomized 482 patients with unprotected left main stenosis to DK crush vs provisional stenting and followed them up to 3 years. Primary end point was target vessel failure (death, target vessel MI and target vessel revascularization). Safety end point was stent thrombosis. Patients were classified according to lesion complexity using the Syntax score, among others.

After 3 years, target vessel failure rate occurred in 16.9% of the provisional stent group vs. 8.3% in the DK crush group (p=0.005). This difference was mainly driven by a higher rate of target vessel MI (5.8% vs 1.7%; p=0.017) and higher target vessel revascularization rate (10.3% vs 5%; p=0.029) in the provisional stenting arm. 


Read also: TAVR Offers Better Quality of Life to Low Risk Patients.


Definite or probable thrombosis at 3 years resulted 4.1% for the provisional stenting arm and 0.4% for the DK crush arm (0.006). 

It is worth mentioning that DK crush was associated with a significant reduction both in the efficacy and safety end points in unprotected left main complex lesions.

Conclusion

The provisional stenting technique to treat left main lesions resulted in more target vessel MI, more target vessel revascularization and more stent thrombosis compared against the double kissing crush technique. This is the first of several randomized studies needed to gather definite evidence. 

Original Title: Three-Year Outcomes of the DKCRUSH-V Trial Comparing DK Crush With Provisional Stenting for Left Main Bifurcation Lesions.

Reference: Xiang Chen et al. J Am Coll Cardiol Intv 2019. Online before print.



Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

CRT 2026 | CUT-DRESS Trial: Lesion Preparation with Cutting Balloon

In-stent restenosis (ISR) continues to represent a relevant clinical challenge in contemporary coronary angioplasty practice. Despite advances in drug-eluting stents, neointimal hyperplasia and suboptimal...

CRT 2026 | Clopidogrel vs Aspirin as Long-Term Monotherapy After Coronary Angioplasty

The use of aspirin as chronic antiplatelet therapy after percutaneous coronary intervention (PCI) has historically been the standard recommended by international guidelines. However, recent...

Bioresorbable devices vs DES in patients at high risk of restenosis. Seven-year follow-up of the COMPARE-ABSORB trial

Studies with second-generation drug-eluting stents (DES) have shown that the rate of target lesion failure (TLF) increases linearly up to 5–10 years of follow-up,...

Sheathless Femoral Impella: A New Strategy to Reduce Vascular Complications in High-Risk PCI?

Patients with complex coronary artery disease or cardiogenic shock undergoing percutaneous coronary intervention (PCI) may benefit from the hemodynamic support provided by percutaneous ventricular...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

CRT 2026 | TAVI-CLOSE Trial: Dual Suture vs Suture + Plug for Vascular Closure After Transfemoral TAVI

The transfemoral approach is the predominant strategy for transcatheter aortic valve implantation (TAVI). Although vascular complications are currently less frequent, they remain relevant determinants...

CRT 2026 | NAVITOR IDE: Hemodynamic Outcomes and 5-Year Durability of an Intra-Annular Self-Expanding Transcatheter Aortic Valve

As TAVI expands into younger populations and patients with lower surgical risk, prosthesis durability has become a key aspect of long-term management. The NAVITOR...

CRT 2026 | CUT-DRESS Trial: Lesion Preparation with Cutting Balloon

In-stent restenosis (ISR) continues to represent a relevant clinical challenge in contemporary coronary angioplasty practice. Despite advances in drug-eluting stents, neointimal hyperplasia and suboptimal...